Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT03199703

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
Jason Andrade (from the registry)
Registry
  • NCT NCT03199703
Other papers using this trial's data
  • Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022-11 DOI, PubMed 35739438, PMC9640463 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03199703. Randomized; no masking; primary purpose treatment. Start 2017-01-17 (actual); primary completion 2019-05-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
Acronym
CRYO-LATS
Intervention (Device)
Baylis transseptal system group
Intervention (Device)
Standard conventional transseptal group
Lead sponsor
Jason Andrade (class: other)
Collaborator
Baylis Medical Company (class: industry)

Record details

Record id
cardio:ct-nct03199703
Content hash
0da27baa9f9d0f06bbf443eb941f1f0493e668db39f04762a1988d2621a0332d